{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:50Z","timestamp":1792784870188,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007732","name":"American Macular Degeneration Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ocugen Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Degeneration of the macula is associated with several overlapping diseases including age-related macular degeneration (AMD) and Stargardt Disease (STGD). Mutations in ATP Binding Cassette Subfamily A Member 4 (\n                    <jats:italic>ABCA4<\/jats:italic>\n                    ) are associated with late-onset dry AMD and early-onset STGD. Additionally, both forms of macular degeneration exhibit deposition of subretinal material and photoreceptor degeneration. Retinoic acid related orphan receptor \u03b1 (\n                    <jats:italic>RORA<\/jats:italic>\n                    ) regulates the AMD inflammation pathway that includes\n                    <jats:italic>ABCA4, CD59, C3<\/jats:italic>\n                    and\n                    <jats:italic>C5<\/jats:italic>\n                    . In this translational study, we examined the efficacy of\n                    <jats:italic>RORA<\/jats:italic>\n                    at attenuating retinal degeneration and improving the inflammatory response in\n                    <jats:italic>Abca4<\/jats:italic>\n                    knockout (\n                    <jats:italic>Abca4<\/jats:italic>\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    ) mice. AAV5-\n                    <jats:italic>hRORA-<\/jats:italic>\n                    treated mice showed reduced deposits, restored CD59 expression and attenuated amyloid precursor protein (APP) expression compared with untreated eyes. This molecular rescue correlated with statistically significant improvement in photoreceptor function. This is the first study evaluating the impact of\n                    <jats:italic>RORA<\/jats:italic>\n                    modifier gene therapy on rescuing retinal degeneration. Our studies demonstrate efficacy of\n                    <jats:italic>RORA<\/jats:italic>\n                    in improving STGD and dry AMD-like disease.\n                  <\/jats:p>","DOI":"10.1038\/s41434-024-00455-z","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T10:02:19Z","timestamp":1715853739000},"page":"413-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Retinoic acid related orphan receptor \u03b1 is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-119X","authenticated-orcid":false,"given":"M.","family":"Akula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"McNamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Nasraty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. P. M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. O.","family":"Avola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. D.","family":"Leehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Jelcick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6283-8843","authenticated-orcid":false,"given":"D. F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-9583","authenticated-orcid":false,"given":"N. B.","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"455_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134\u201343.","journal-title":"Nat Genet"},{"key":"455_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.visres.2009.09.016","volume":"50","author":"AC Silveira","year":"2010","unstructured":"Silveira AC, Morrison MA, Ji F, Xu H, Reinecke JB, Adams SM, et al. Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vis Res. 2010;50:698\u2013715.","journal-title":"Vis Res"},{"key":"455_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/opo.12675","volume":"40","author":"TJ Heesterbeek","year":"2020","unstructured":"Heesterbeek TJ, Lores-Motta L, Hoyng CB, Lechanteur YTE, den Hollander AI. Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt. 2020;40:140\u201370.","journal-title":"Ophthalmic Physiol Opt"},{"key":"455_CR4","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1093\/hmg\/ddx228","volume":"26","author":"MM DeAngelis","year":"2017","unstructured":"DeAngelis MM, Owen LA, Morrison MA, Morgan DJ, Li M, Shakoor A, et al. Genetics of age-related macular degeneration (AMD). Hum Mol Genet. 2017;26:R45\u2013R50.","journal-title":"Hum Mol Genet"},{"key":"455_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/1479-7364-5-6-538","volume":"5","author":"MA Morrison","year":"2011","unstructured":"Morrison MA, Silveira AC, Huynh N, Jun G, Smith SE, Zacharaki F, et al. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genom. 2011;5:538\u201368.","journal-title":"Hum Genom"},{"key":"455_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1124\/mi.10.5.4","volume":"10","author":"Y Chen","year":"2010","unstructured":"Chen Y, Bedell M, Zhang K. Age-related macular degeneration: genetic and environmental factors of disease. Mol Inter. 2010;10:271\u201381.","journal-title":"Mol Inter"},{"key":"455_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.759333","volume":"11","author":"W Xue","year":"2021","unstructured":"Xue W, Li JJ, Zou Y, Zou B, Wei L. Microbiota and ocular diseases. Front Cell Infect Microbiol. 2021;11:759333.","journal-title":"Front Cell Infect Microbiol"},{"key":"455_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.mam.2012.06.003","volume":"33","author":"ME Pennesi","year":"2012","unstructured":"Pennesi ME, Neuringer M, Courtney RJ. Animal models of age related macular degeneration. Mol Asp Med. 2012;33:487\u2013509.","journal-title":"Mol Asp Med"},{"key":"455_CR9","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","volume":"43","author":"NM Schultz","year":"2021","unstructured":"Schultz NM, Bhardwaj S, Barclay C, Gaspar L, Schwartz J. Global burden of dry age-related macular degeneration: a targeted literature review. Clin Ther. 2021;43:1792\u2013818.","journal-title":"Clin Ther"},{"key":"455_CR10","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/jcm10081785","volume":"10","author":"T Maeda","year":"2021","unstructured":"Maeda T, Sugita S, Kurimoto Y, Takahashi M. Trends of stem cell therapies in age-related macular degeneration. J Clin Med. 2021;10:1785.","journal-title":"J Clin Med"},{"key":"455_CR11","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u201316.","journal-title":"Lancet Glob Health"},{"key":"455_CR12","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3390\/jcm10153297","volume":"10","author":"E Di Carlo","year":"2021","unstructured":"Di Carlo E, Augustin AJ. Prevention of the onset of age-related macular degeneration. J Clin Med. 2021;10:3297.","journal-title":"J Clin Med"},{"key":"455_CR13","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ajo.2013.01.018","volume":"155","author":"K Fujinami","year":"2013","unstructured":"Fujinami K, Lois N, Davidson AE, Mackay DS, Hogg CR, Stone EM, et al. A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol. 2013;155:1075\u201388.e13.","journal-title":"Am J Ophthalmol"},{"key":"455_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/bs.pmbts.2015.06.008","volume":"134","author":"RS Molday","year":"2015","unstructured":"Molday RS. Insights into the molecular properties of ABCA4 and its role in the visual cycle and stargardt disease. Prog Mol Biol Transl Sci. 2015;134:415\u201331.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"455_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ophtha.2015.12.009","volume":"123","author":"RW Strauss","year":"2016","unstructured":"Strauss RW, Ho A, Mu\u00f1oz B, Cideciyan AV, Sahel JA, Sunness JS, et al. The natural history of the progression of atrophy secondary to Stargardt disease (ProgStar) studies: design and baseline characteristics: progstar report No. 1. Ophthalmology. 2016;123:817\u201328.","journal-title":"Ophthalmology"},{"key":"455_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/13816810.2011.565397","volume":"32","author":"TR Burke","year":"2011","unstructured":"Burke TR, Tsang SH. Allelic and phenotypic heterogeneity in ABCA4 mutations. Ophthalmic Genet. 2011;32:165\u201374.","journal-title":"Ophthalmic Genet"},{"key":"455_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ophtha.2014.08.032","volume":"122","author":"S Lambertus","year":"2015","unstructured":"Lambertus S, van Huet RA, Bax NM, Hoefsloot LH, Cremers FP, Boon CJ, et al. Early-onset Stargardt disease: phenotypic and genotypic characteristics. Ophthalmology. 2015;122:335\u201344.","journal-title":"Ophthalmology"},{"key":"455_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ajo.2019.11.008","volume":"211","author":"M Georgiou","year":"2020","unstructured":"Georgiou M, Kane T, Tanna P, Bouzia Z, Singh N, Kalitzeos A, et al. Prospective cohort study of childhood-onset stargardt disease: fundus autofluorescence imaging, progression, comparison with adult-onset disease, and disease symmetry. Am J Ophthalmol. 2020;211:159\u201375.","journal-title":"Am J Ophthalmol"},{"key":"455_CR19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.ophtha.2012.01.005","volume":"119","author":"SC Westeneng-van Haaften","year":"2012","unstructured":"Westeneng-van Haaften SC, Boon CJ, Cremers FP, Hoefsloot LH, den Hollander AI, Hoyng CB. Clinical and genetic characteristics of late-onset Stargardt\u2019s disease. Ophthalmology. 2012;119:1199\u2013210.","journal-title":"Ophthalmology"},{"key":"455_CR20","first-page":"13","volume":"6","author":"TS Oluleye","year":"2013","unstructured":"Oluleye TS, Aina AS, Sarimiye TF, Olaniyan SI. Stargadt\u2019s disease in two Nigerian siblings. Int Med Case Rep J. 2013;6:13\u20135.","journal-title":"Int Med Case Rep J"},{"key":"455_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/bjophthalmol-2020-316201","volume":"105","author":"M Pfau","year":"2021","unstructured":"Pfau M, Holz FG, Muller PL. Retinal light sensitivity as outcome measure in recessive Stargardt disease. Br J Ophthalmol. 2021;105:258\u201364.","journal-title":"Br J Ophthalmol"},{"key":"455_CR22","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1167\/iovs.13-11688","volume":"54","author":"P Charbel Issa","year":"2013","unstructured":"Charbel Issa P, Barnard AR, Singh MS, Carter E, Jiang Z, Radu RA, et al. Fundus autofluorescence in the Abca4(-\/-) mouse model of Stargardt disease-correlation with accumulation of A2E, retinal function, and histology. Invest Ophthalmol Vis Sci. 2013;54:5602\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"455_CR23","first-page":"1685","volume":"42","author":"NL Mata","year":"2001","unstructured":"Mata NL, Tzekov RT, Liu X, Weng J, Birch DG, Travis GH. Delayed dark-adaptation and lipofuscin accumulation in abcr+\/- mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2001;42:1685\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"455_CR24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0161-6420(91)32196-1","volume":"98","author":"GA Fishman","year":"1991","unstructured":"Fishman GA, Farbman JS, Alexander KR. Delayed rod dark adaptation in patients with Stargardt\u2019s disease. Ophthalmology. 1991;98:957\u201362.","journal-title":"Ophthalmology"},{"key":"455_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000438906","volume":"54","author":"T Vandenbroucke","year":"2015","unstructured":"Vandenbroucke T, Buyl R, De Zaeytijd J, Bauwens M, Uvijls A, De Baere E, et al. Colour vision in Stargardt disease. Ophthalmic Res. 2015;54:181\u201394.","journal-title":"Ophthalmic Res"},{"key":"455_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101787","volume":"37","author":"J Hu","year":"2020","unstructured":"Hu J, Pauer GJ, Hagstrom SA, Bok D, DeBenedictis MJ, Bonilha VL, et al. Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes. Redox Biol. 2020;37:101787.","journal-title":"Redox Biol"},{"key":"455_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"DS Liao","year":"2020","unstructured":"Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, et al. Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial. Ophthalmology. 2020;127:186\u201395.","journal-title":"Ophthalmology"},{"key":"455_CR28","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","volume":"128","author":"GJ Jaffe","year":"2021","unstructured":"Jaffe GJ, Westby K, Csaky KG, Mones J, Pearlman JA, Patel SS, et al. C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial. Ophthalmology. 2021;128:576\u201386.","journal-title":"Ophthalmology"},{"key":"455_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/OPTH.S367089","volume":"17","author":"H Khan","year":"2023","unstructured":"Khan H, Aziz AA, Sulahria H, Khan H, Ahmed A, Choudhry N, et al. Emerging treatment options for geographic atrophy (GA) secondary to age-related macular degeneration. Clin Ophthalmol. 2023;17:321\u20137.","journal-title":"Clin Ophthalmol"},{"key":"455_CR30","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1126\/science.277.5333.1805","volume":"277","author":"R Allikmets","year":"1997","unstructured":"Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997;277:1805\u20137.","journal-title":"Science"},{"key":"455_CR31","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1167\/iovs.11-8785","volume":"53","author":"LG Fritsche","year":"2012","unstructured":"Fritsche LG, Fleckenstein M, Fiebig BS, Schmitz-Valckenberg S, Bindewald-Wittich A, Keilhauer CN, et al. A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene. Invest Ophthalmol Vis Sci. 2012;53:2112\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"455_CR32","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/hmg\/10.23.2671","volume":"10","author":"NF Shroyer","year":"2001","unstructured":"Shroyer NF, Lewis RA, Yatsenko AN, Wensel TG, Lupski JR. Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet. 2001;10:2671\u20138.","journal-title":"Hum Mol Genet"},{"key":"455_CR33","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fnins.2018.00464","volume":"12","author":"A Moreno-Garcia","year":"2018","unstructured":"Moreno-Garcia A, Kun A, Calero O, Medina M, Calero M. An overview of the role of lipofuscin in age-related neurodegeneration. Front Neurosci. 2018;12:464.","journal-title":"Front Neurosci"},{"key":"455_CR34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/path.4128","volume":"229","author":"KB Ebrahimi","year":"2013","unstructured":"Ebrahimi KB, Fijalkowski N, Cano M, Handa JT. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration. J Pathol. 2013;229:729\u201342.","journal-title":"J Pathol"},{"key":"455_CR35","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.3390\/ijms21228468","volume":"21","author":"Y Jabri","year":"2020","unstructured":"Jabri Y, Biber J, Diaz-Lezama N, Grosche A, Pauly D. Cell-type-specific complement profiling in the ABCA4(-\/-) mouse model of stargardt disease. Int J Mol Sci. 2020;21:8468.","journal-title":"Int J Mol Sci"},{"key":"455_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.exer.2019.05.006","volume":"184","author":"R Kumar-Singh","year":"2019","unstructured":"Kumar-Singh R. The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials. Exp Eye Res. 2019;184:266\u201377.","journal-title":"Exp Eye Res"},{"key":"455_CR37","doi-asserted-by":"publisher","first-page":"8789","DOI":"10.1073\/pnas.1523061113","volume":"113","author":"LX Tan","year":"2016","unstructured":"Tan LX, Toops KA, Lakkaraju A. Protective responses to sublytic complement in the retinal pigment epithelium. Proc Natl Acad Sci USA. 2016;113:8789\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"455_CR38","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1136\/bjo.2007.118356","volume":"91","author":"M Michaelides","year":"2007","unstructured":"Michaelides M, Chen LL, Brantley MA Jr., Andorf JL, Isaak EM, Jenkins SA, et al. ABCA4 mutations and discordant ABCA4 alleles in patients and siblings with bull\u2019s-eye maculopathy. Br J Ophthalmol. 2007;91:1650\u20135.","journal-title":"Br J Ophthalmol"},{"key":"455_CR39","first-page":"300","volume":"28","author":"U Kjellstrom","year":"2022","unstructured":"Kjellstrom U, Andreasson S. A five-year follow-up of ABCA4 carriers showing deterioration of retinal function and increased structural changes. Mol Vis. 2022;28:300\u201316.","journal-title":"Mol Vis"},{"key":"455_CR40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ng0397-236","volume":"15","author":"R Allikmets","year":"1997","unstructured":"Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy. Nat Genet. 1997;15:236\u201346.","journal-title":"Nat Genet"},{"key":"455_CR41","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1167\/iovs.13-12570","volume":"54","author":"K Fujinami","year":"2013","unstructured":"Fujinami K, Zernant J, Chana RK, Wright GA, Tsunoda K, Ozawa Y, et al. ABCA4 gene screening by next-generation sequencing in a British cohort. Invest Ophthalmol Vis Sci. 2013;54:6662\u201374.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"455_CR42","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.1167\/iovs.11-8182","volume":"52","author":"J Zernant","year":"2011","unstructured":"Zernant J, Schubert C, Im KM, Burke T, Brown CM, Fishman GA, et al. Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci. 2011;52:8479\u201387.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"455_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/ddh048","volume":"13","author":"AV Cideciyan","year":"2004","unstructured":"Cideciyan AV, Aleman TS, Swider M, Schwartz SB, Steinberg JD, Brucker AJ, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525\u201334.","journal-title":"Hum Mol Genet"},{"key":"455_CR44","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.ophtha.2016.05.041","volume":"123","author":"M Pellegrini","year":"2016","unstructured":"Pellegrini M, Acquistapace A, Oldani M, Cereda MG, Giani A, Cozzi M, et al. Dark atrophy: an optical coherence tomography angiography study. Ophthalmology. 2016;123:1879\u201386.","journal-title":"Ophthalmology"},{"key":"455_CR45","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1167\/iovs.19-27524","volume":"60","author":"EH Runhart","year":"2019","unstructured":"Runhart EH, Valkenburg D, Cornelis SS, Khan M, Sangermano R, Albert S, et al. Late-onset Stargardt disease due to mild, deep-intronic ABCA4 alleles. Invest Ophthalmol Vis Sci. 2019;60:4249\u201356.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"455_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41434-020-0134-z","volume":"28","author":"S Li","year":"2021","unstructured":"Li S, Datta S, Brabbit E, Love Z, Woytowicz V, Flattery K, et al. Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa. Gene Ther. 2021;28:223\u201341.","journal-title":"Gene Ther"},{"key":"455_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18632\/aging.204480","volume":"15","author":"CH Liu","year":"2023","unstructured":"Liu CH, Yemanyi F, Bora K, Kushwah N, Blomfield AK, Kamenecka TM, et al. Genetic deficiency and pharmacological modulation of RORalpha regulate laser-induced choroidal neovascularization. Aging. 2023;15:37\u201352.","journal-title":"Aging"},{"key":"455_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00788-3","volume":"7","author":"AM Olivares","year":"2017","unstructured":"Olivares AM, Jelcick AS, Reinecke J, Leehy B, Haider A, Morrison MA, et al. Multimodal regulation orchestrates normal and complex disease states in the retina. Sci Rep. 2017;7:690.","journal-title":"Sci Rep"},{"key":"455_CR49","doi-asserted-by":"publisher","first-page":"e25775","DOI":"10.1371\/journal.pone.0025775","volume":"6","author":"G Jun","year":"2011","unstructured":"Jun G, Nicolaou M, Morrison MA, Buros J, Morgan DJ, Radeke MJ, et al. Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS ONE. 2011;6:e25775.","journal-title":"PLoS ONE"},{"key":"455_CR50","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.1073\/pnas.1506960112","volume":"112","author":"P Charbel Issa","year":"2015","unstructured":"Charbel Issa P, Barnard AR, Herrmann P, Washington I, MacLaren RE. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. Proc Natl Acad Sci USA. 2015;112:8415\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"455_CR51","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1089\/104303403322542301","volume":"14","author":"AJ Lotery","year":"2003","unstructured":"Lotery AJ, Yang GS, Mullins RF, Russell SR, Schmidt M, Stone EM, et al. Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina. Hum Gene Ther. 2003;14:1663\u201371.","journal-title":"Hum Gene Ther"},{"key":"455_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0092-8674(00)80602-9","volume":"98","author":"J Weng","year":"1999","unstructured":"Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt\u2019s disease from the phenotype in ABCR knockout mice. Cell. 1999;98:13\u201323.","journal-title":"Cell"},{"key":"455_CR53","doi-asserted-by":"publisher","first-page":"e21858","DOI":"10.1371\/journal.pone.0021858","volume":"6","author":"AS Jelcick","year":"2011","unstructured":"Jelcick AS, Yuan Y, Leehy BD, Cox LC, Silveira AC, Qiu F, et al. Genetic variations strongly influence phenotypic outcome in the mouse retina. PLoS ONE. 2011;6:e21858.","journal-title":"PLoS ONE"},{"key":"455_CR54","doi-asserted-by":"publisher","first-page":"e17494","DOI":"10.1371\/journal.pone.0017494","volume":"6","author":"NJ Mollema","year":"2011","unstructured":"Mollema NJ, Yuan Y, Jelcick AS, Sachs AJ, von Alpen D, Schorderet D, et al. Nuclear receptor Rev-erb alpha (Nr1d1) functions in concert with Nr2e3 to regulate transcriptional networks in the retina. PLoS ONE. 2011;6:e17494.","journal-title":"PLoS ONE"},{"key":"455_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpmo.39","volume":"8","author":"J Kinoshita","year":"2018","unstructured":"Kinoshita J, Peachey NS. Noninvasive electroretinographic procedures for the study of the mouse retina. Curr Protoc Mouse Biol. 2018;8:1\u201316.","journal-title":"Curr Protoc Mouse Biol"},{"key":"455_CR56","doi-asserted-by":"publisher","first-page":"e87942","DOI":"10.1371\/journal.pone.0087942","volume":"9","author":"NM Cruz","year":"2014","unstructured":"Cruz NM, Yuan Y, Leehy BD, Baid R, Kompella U, DeAngelis MM, et al. Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease. PLoS ONE. 2014;9:e87942.","journal-title":"PLoS ONE"},{"key":"455_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00335-008-9092-2","volume":"19","author":"NB Haider","year":"2008","unstructured":"Haider NB, Zhang W, Hurd R, Ikeda A, Nystuen AM, Naggert JK, et al. Mapping of genetic modifiers of Nr2e3 rd7\/rd7 that suppress retinal degeneration and restore blue cone cells to normal quantity. Mamm Genome. 2008;19:145\u201354.","journal-title":"Mamm Genome"},{"key":"455_CR58","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"455_CR59","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447\u201352.","journal-title":"Nucleic Acids Res"},{"key":"455_CR60","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1167\/iovs.12-10849","volume":"54","author":"RT Liu","year":"2013","unstructured":"Liu RT, Gao J, Cao S, Sandhu N, Cui JZ, Chou CL, et al. Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54:2225\u201337.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"455_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108061","volume":"196","author":"H Huang","year":"2020","unstructured":"Huang H, Lennikov A. CXCR5\/NRF2 double knockout mice develop retinal degeneration phenotype at early adult age. Exp Eye Res. 2020;196:108061.","journal-title":"Exp Eye Res"},{"key":"455_CR62","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3389\/fimmu.2019.01903","volume":"10","author":"A Lennikov","year":"2019","unstructured":"Lennikov A, Saddala MS, Mukwaya A, Tang S, Huang H. Autoimmune-mediated retinopathy in cxcr5-deficient mice as the result of age-related macular degeneration associated proteins accumulation. Front Immunol. 2019;10:1903.","journal-title":"Front Immunol"},{"key":"455_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.exer.2003.10.011","volume":"78","author":"DH Anderson","year":"2004","unstructured":"Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res. 2004;78:243\u201356.","journal-title":"Exp Eye Res"},{"key":"455_CR64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-1-4419-1399-9_38","volume":"664","author":"Y Chen","year":"2010","unstructured":"Chen Y, Roorda A, Duncan JL. Advances in imaging of Stargardt disease. Adv Exp Med Biol. 2010;664:333\u201340.","journal-title":"Adv Exp Med Biol"},{"key":"455_CR65","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/OPX.0000000000000997","volume":"94","author":"A Ly","year":"2017","unstructured":"Ly A, Nivison-Smith L, Assaad N, Kalloniatis M. Fundus autofluorescence in age-related macular degeneration. Optom Vis Sci. 2017;94:246\u201359.","journal-title":"Optom Vis Sci"},{"key":"455_CR66","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2147\/CIA.S143508","volume":"12","author":"WM Al-Zamil","year":"2017","unstructured":"Al-Zamil WM, Yassin SA. Recent developments in age-related macular degeneration: a review. Clin Inter Aging. 2017;12:1313\u201330.","journal-title":"Clin Inter Aging"},{"key":"455_CR67","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1089\/hum.2019.132","volume":"30","author":"FM Dyka","year":"2019","unstructured":"Dyka FM, Molday LL, Chiodo VA, Molday RS, Hauswirth WW. Dual ABCA4-AAV vector treatment reduces pathogenic retinal A2E accumulation in a mouse model of autosomal recessive stargardt disease. Hum Gene Ther. 2019;30:1361\u201370.","journal-title":"Hum Gene Ther"},{"key":"455_CR68","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1073\/pnas.0702504104","volume":"104","author":"A Lakkaraju","year":"2007","unstructured":"Lakkaraju A, Finnemann SC, Rodriguez-Boulan E. The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc Natl Acad Sci USA. 2007;104:11026\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"455_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101074","volume":"297","author":"D Zhang","year":"2021","unstructured":"Zhang D, Robinson K, Saad L, Washington I. Vitamin A cycle byproducts impede dark adaptation. J Biol Chem. 2021;297:101074.","journal-title":"J Biol Chem"},{"key":"455_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0337-1","volume":"12","author":"T Zhao","year":"2015","unstructured":"Zhao T, Gao J, Van J, To E, Wang A, Cao S, et al. Age-related increases in amyloid beta and membrane attack complex: evidence of inflammasome activation in the rodent eye. J Neuroinflammation. 2015;12:121.","journal-title":"J Neuroinflammation"},{"key":"455_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.502","volume":"8","author":"J Sun","year":"2017","unstructured":"Sun J, Huang P, Liang J, Li J, Shen M, She X, et al. Cooperation of Rel family members in regulating Abeta(1-40)-mediated pro-inflammatory cytokine secretion by retinal pigment epithelial cells. Cell Death Dis. 2017;8:e3115.","journal-title":"Cell Death Dis"},{"key":"455_CR72","doi-asserted-by":"publisher","first-page":"e13127","DOI":"10.1371\/journal.pone.0013127","volume":"5","author":"J Hoh Kam","year":"2010","unstructured":"Hoh Kam J, Lenassi E, Jeffery G. Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages. PLoS ONE. 2010;5:e13127.","journal-title":"PLoS ONE"},{"key":"455_CR73","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1167\/iovs.08-1849","volume":"49","author":"A Ning","year":"2008","unstructured":"Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci. 2008;49:5136\u201343.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"455_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103327","volume":"24","author":"J Zhang","year":"2021","unstructured":"Zhang J, Gao F, Ma Y, Xue T, Shen Y. Identification of early-onset photoreceptor degeneration in transgenic mouse models of Alzheimer\u2019s disease. iScience. 2021;24:103327.","journal-title":"iScience"},{"key":"455_CR75","doi-asserted-by":"publisher","first-page":"e29892","DOI":"10.1371\/journal.pone.0029892","volume":"7","author":"T Ho","year":"2012","unstructured":"Ho T, Vessey KA, Cappai R, Dinet V, Mascarelli F, Ciccotosto GD, et al. Amyloid precursor protein is required for normal function of the rod and cone pathways in the mouse retina. PLoS ONE. 2012;7:e29892.","journal-title":"PLoS ONE"},{"key":"455_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-016-0079-x","volume":"10","author":"PL Tan","year":"2016","unstructured":"Tan PL, Bowes Rickman C, Katsanis N. AMD and the alternative complement pathway: genetics and functional implications. Hum Genom. 2016;10:23.","journal-title":"Hum Genom"},{"key":"455_CR77","first-page":"93","volume":"9","author":"AM Olivares","year":"2015","unstructured":"Olivares AM, Moreno-Ramos OA, Haider NB. Role of nuclear receptors in central nervous system development and associated diseases. J Exp Neurosci. 2015;9:93\u2013121.","journal-title":"J Exp Neurosci"},{"key":"455_CR78","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3390\/ijms22052360","volume":"22","author":"L Wang","year":"2021","unstructured":"Wang L, Mao X. Role of retinal amyloid-beta in neurodegenerative diseases: overlapping mechanisms and emerging clinical applications. Int J Mol Sci. 2021;22:2360.","journal-title":"Int J Mol Sci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-024-00455-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-024-00455-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-024-00455-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T10:02:32Z","timestamp":1721296952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-024-00455-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":78,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1038\/s41434-024-00455-z","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institute of Health, as well as the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}